Home > Browse Research > Life Sciences > Biotechnology > Genetic Engineering

Genetic Engineering: market research reports

Genetic Engineering (GE), or genetic modification, is the manipulation of an organism’s DNA sequence. Using recombinant DNA technology, or gene splicing, segments of a DNA are taken out and replaced changing the genetic makeup of the organism.

Applications of GE include genetically modified foods, gene therapy, germ-line therapy and cloning. Although they have all spurred debate, one topic, which has been particularly controversial, is the use of genetically modified foods.

Genetically modified foods have found their place in today’s world with the decreasing effectiveness of synthetic pesticides used in agriculture and the world hunger crisis. Genetically modified foods can decrease the need for pesticides by increasing the crops resistance to these harmful chemicals. This can increase the harvest of many chief crops, in turn warding off starvation in many global populations.

Despite the benefits of genetically modifying food, critics have numerous concerns. One argument centers on its effect on wild populations, fearing that genetically engineered crops might transmit their modified genes to convention crops or species, creating organisms which humans have no defense for.

Another argument centers on allergenicity. There is the potential for genetically modified foods to contain allergenic proteins, making these foods dangerous for some people.

Genetic Engineering market research reports and industry analysis

China Genetic Engineering Drug Industry Report, 2011-2012 6/1/2012 \| published by: Research in China ... growth rate of genetic engineering drug market in China is as high as 49%, with an average gross margin of more than 80%. However, the technology strength and efficacy of locally produced genetic engineering drugs ... \| read more...	$1,900.00
Genetic Engineering 1/1/2012 \| published by: Global Industry Analysts ... issues and concerns, and regulatory environment. Discussion on the industry’s most noteworthy regional market, the US, is amply detailed with unbiased research commentary to provide the reader a rudimentary understanding of the prevailing market climate. ... \| read more...	$1,995.00
Biotechnology Sector 3/14/2011 \| published by: First Research, Inc. ... Life Technologies, and Monsanto. Because many drugs are now developed using biotechnology, the biotechnology and pharmaceutical industries overlap considerably. COMPETITIVE LANDSCAPE Demand for biotechnology research in the fields of medicine, agriculture, food, and science is ... \| read more...	$129.00
Stem Cell Markets 6/1/2010 \| published by: TriMark Publications ... have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ ... \| read more...	$3,400.00
Patent map and technology intelligence report. Micro-organisms/Enzymes; Propagating, Preserving Or Maintaining Micro-organisms; Genetic Engineering; Culture Media 1/24/2010 \| published by: Intellectual Property Exchange ... or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof; Enzymes, e.g. ligases; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, ... \| read more...	$1,200.00
The World Market for Biosimilars and the Potential for US Follow-on Biologics 8/1/2009 \| published by: Kalorama Information ... areas in the world and the possibility of a U.S. Market in the near future. As part of its research, this Kalormaa Information report provides the following Current market size and forecasts for biogenerics in ... \| read more...	$3,700.00
Choices In Cord Blood Banking: Factors Influencing Parental Decision-Making 4/1/2009 \| published by: BioInformant Worldwide, L.L.C. ... genetic and metabolic disorders, immunodeficiencies and various forms of cancer. However, many expectant parents still do not fully understand the significance of cord blood storage. A study published in the Journal of Reproductive Medicine shows ... \| read more...	$3,295.00
The 2009 Report on Gene Expression Services: World Market Segmentation by City 1/5/2009 \| published by: Icon Group International, Inc. ... as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major ... \| read more...	$795.00
The 2009-2014 Outlook for Gene Expression Services in Greater China 12/2/2008 \| published by: Icon Group International, Inc. ... Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities ... \| read more...	$495.00
The 2009-2014 Outlook for Gene Expression Services in India 12/2/2008 \| published by: Icon Group International, Inc. ... given across over 5,000 cities in India. For each city in question, the percent share the city is of it’s state or union territory and of India as a whole is reported. These comparative benchmarks ... \| read more...	$495.00
The 2009-2014 Outlook for Gene Expression Services in the United States 12/2/2008 \| published by: Icon Group International, Inc. ... given across some 12,900 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States is reported. These comparative benchmarks allow the ... \| read more...	$495.00
The 2009-2014 Outlook for Gene Expression Services in Japan 12/2/2008 \| published by: Icon Group International, Inc. ... some 1,000 cities in Japan. For each city in question, the percent share the city is of it’s prefecture and of Japan is reported. These comparative benchmarks allow the reader to quickly gauge a city ... \| read more...	$495.00
Biopharmaceutical Expression Systems and Genetic Engineering Technology 11/1/2008 \| published by: BioPlan Associates, Inc. ... all the information you need to begin the shift to increased productivity. Since the 1970s little has changed in the technologies used for commercial-scale biomanufacturing (E. coli, CHO cells, or S. cerevisiae as hosts). But ... \| read more...	$645.00
The 2009-2014 World Outlook for Gene Expression Services 9/20/2008 \| published by: Icon Group International, Inc. ... in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... \| read more...	$795.00
Stem Cell Technology: Current Applications and Future Directions 7/1/2008 \| published by: BCC Research ... applications and documents trends that impact product demand. Segments markets by both technology and application. Covers the latest stem cell research and commercialization advances with implications for end users such as the healthcare market as ... \| read more...	$5,450.00
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 3/1/2008 \| published by: Kalorama Information ... to test emerging therapies on diseased cells. For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem ... \| read more... Buy by the section \|	$995.00
Cell Therapy Markets 7/1/2007 \| published by: TriMark Publications ... become a part of medical practice. Unlike organs, cells are a potentially renewable resource for body repair. The goal of this TriMark Publications report is to review the market for cell therapy products using screening ... \| read more...	$3,400.00
Developments in Stem Cell Research (Technical Insights) 3/31/2007 \| published by: Frost & Sullivan ... the same. A section on SWOT analysis of stem cell research provides the reader with some useful insights that would enable an entrant or a mature participant in the market take appropriate measures to improve ... \| read more...	$6,000.00
Hitting the Bull's-Eye with Your Eyes Closed: The Stem Cell Magic Bullet 12/22/2006 \| published by: IDC ... directions, including as new experimental therapies in human subjects. Stem cells are also the center of political (and as a result, financial) controversies that are affecting how stem cell research is both funded and performed. ... \| read more...	$500.00
New Options for Treating Neurological Disease: Stem Cell Therapy 12/6/2006 \| published by: Decision Resources ... diseases. Get the Answers You Need to Shape Your Strategy Stem cell therapy holds vast potential for treating degeneration or injury in areas of the body that are incapable of autonomous healing, such as the ... \| read more...	$4,600.00
Chemical Genetics in Drug Discovery 11/30/2006 \| published by: Decision Resources ... potential, their ultimate success can be measured only when drug candidates discovered using these technologies reach the marketplace. Questions Answered in This Spectrum Report Although chemical genetics was originally developed for basic biological research, industry ... \| read more...	$4,600.00
Biogenerics 7/1/2006 \| published by: Global Industry Analysts ... of 2007 through 2013. The report profiles 42 companies including many key and niche players worldwide such as Biocon Limited, BioPartners, BioGeneriX AG, Cangene Corporation, Cipla Ltd., Dr. Reddy's Laboratories, GeneMedix, LG Life Sciences, Pliva ... \| read more...	$3,950.00
DNA Market in China: An Analysis 5/1/2006 \| published by: RocSearch ... a growing market in DNA technology-based products and services. The report examines the role of these technologies in shaping the landscape of the Chinese DNA market. The report studies the external and internal environment of ... \| read more...	$1,500.00
The Market for DNA Molecular Weight Markers: Climbing the Ladder to the Top 4/1/2006 \| published by: BioInformatics, LLC ... potential to produce a constant revenue stream for suppliers because of high profit margins, suppliers must constantly search for ways to ensure that scientists buy their brand DNA molecular weight markers -- and not their ... \| read more...	$500.00
Biotechnology Up-Stream and Down-Stream Processing Technology Analysis (Technical Insights) 3/31/2006 \| published by: Frost & Sullivan ... cells, and eggs. It also includes an in-depth analysis of new separation technologies for downstream processing and technologies for genetically engineering more potent antibodies and enzymes with higher activity, among others. In this study, Frost ... \| read more...	$6,000.00

< prev 1 2 3 next >